Farzad Nazem
Angel Investor
Palo Alto, United States
Farzad Nazem is a seed investor in Palo Alto focused on Health Care and Software. Farzad (Zod) Nazem has been a prolific angel investor and advisor to tech startup companies since his retirement from Yahoo! in 2007. He has invested in more than 130 early stage companies, and sits on the boards of Hand Foundation, and Nautilus Bio. His area of investment is about half in AI, Big Data and Cloud platforms, and half in Health andBiotech. He was the Executive Vice President of Engineering and Chief Technology Officer of Yahoo from 1996 to mid 2007. He helped acquire and integrate over 50 companies and managed over six thousand engineers representing half of the company's employees. Between 1985 and 1996, Mr. Nazem held various software development and management positions at Oracle Corporation culminating in his role as Vice President of Media and Web Server Division. His tenure at Oracle also included membership in the company's Product Division Management Committee, which set overall strategy for Oracle products. Previously, Mr. Nazem was recruited from California Polytechnic State University by Rolm Corporation to be a software engineer in the VLCBX division. At age 19, he earned a B.S. degree in Computer Science with highest honors.
- Total investments:
- 65
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Farzad Nazem invests in
Stages Farzad Nazem invests in
Countries Farzad Nazem invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $750k–$6.5M
- Series A
- $2.8M–$14M
- Series B
- $6M–$50M
Investment Focus
Industry
- Health Care 14 (22%)
- Software 13 (20%)
- Analytics 12 (18%)
- Enterprise Software 11 (17%)
- Machine Learning 8 (12%)
Stage
- Seed 32 (49%)
- Series A 19 (29%)
- Series B 4 (6%)
- Series C 2 (3%)
- Funding Round 2 (3%)
Country
- United States 52 (80%)
- Canada 2 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Ceevra is an advanced 3D visualization technology for surgeons. Using AI and other innovative computing techniques, Ceevra generates brilliant 3D digital models from standard CT scans and MRIs. Surgeons use the Ceevra 3D models to help educate and counsel patients, to decide on the best surgical approach, and to gain important insights whileoperating. | $1.6M / Seed / Mar 31, 2018 | ||
| TigerGraph is a platform for advanced analytics and machine learning on connected data. Based on the industry’s first and only distributed native graph database, TigerGraph’s proven technology supports advanced analytics and machine learning applications such as fraud detection, anti-money laundering (AML), entity resolution, customer 360,recommendations, knowledge graph, cybersecurity, supply chain, IoT, and network analysis. The company is headquartered in Redwood City, California, USA. Start free with tigergraph.com/cloud. | $31M / Series A / Sep 19, 2017 | ||
| Emailage is a developer of fraud prevention and identity verification technology used to make transactions easier and secure. The company provides multi-faceted predictive solutions with email at the core through key partnerships, proprietary data, and advanced machine-learning technology. It proprietary algorithms in order to provide real-timealerts of risky transactions and delivers a risk score and enable companies to realize significant savings from identifying and stopping fraudulent transactions and improve customer experience. | $5.7M / Series A / Apr 13, 2016 | ||
| Luminist is developing a rapidly scalable, low-cost platform to screen for many diseases. | Seed / Mar 22, 2016 | ||
| OpsClarity is a performance monitoring solution for modern applications and data infrastructure that helps DevOps and engineering teams to continuously visualize, understand and troubleshoot their complex and distributed business-critical applications and infrastructure. Built by alumni from Yahoo, eBay, Facebook, Twitter and Google, OpsClarity isthe only solution that can dynamically adapt to and learn every component of a company’s modern fast data application and infrastructure and extract key insights needed to maximize performance and agility.. | $11M / Series A / Dec 03, 2015 | ||
| Tubi is the world’s largest ad-supported video on demand service with over 12,000 movies and television shows from nearly every major Hollywood studio. The service gives fans of films and television programs an easy way to discover new content which is available completely free. Currently available in the US and Canada, Tubi can be accessed througha large number of devices and apps including Samsung televisions, Roku, Amazon Fire TV, Comcast’s X1, iOS, and Android. | $6M / Series B / Nov 22, 2015 | ||
| Convoy is the nation’s most efficient digital freight network. We move thousands of truckloads around the country each day through our optimized, connected network of carriers, saving money for shippers, increasing earnings for drivers, and eliminating carbon waste for our planet. We use technology and data to solve problems of waste andinefficiency in the $800B trucking industry, which generates over 72 million metric tons of wasted CO2 emissions from empty trucks. Fortune 500 shippers like Anheuser-Busch, P&G, Niagara, and Unilever trust Convoy to lower costs, increase logistics efficiency, and achieve environmental sustainability targets.Convoy was founded in 2015 and is headquartered in Seattle, Washington. | $2.5M / Seed / Oct 26, 2015 | ||
| Eargo is a medical device startup company that produces hearing aids that allow customers to access help for their hearing loss.The company also offers online hearing screenings and virtual support, so customers don’t need to have an in-person visit. It offers a rechargeable hearing aids that can be controlled with a smartphone. Its innovativeproduct and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility, and cost. Consumers can purchase online or over the phone and get personalized and convenient consultation and support from licensed hearing professionals via phone, text, email, or video chat. The Eargo solution is offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels. | $13.6M / Series A / Jun 25, 2015 | ||
| Sano is building a small, wearable sensor that can capture and transmit blood chemistry data continuously to virtually any device. The company will liberate this data to a third-party development and analytical platform called the API for the bloodstream. | $10.3M / Seed / Jun 19, 2015 | ||
| Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any otherAI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. Learn more at atomwise.com, or connect on Twitter and LinkedIn. | $6M / Seed / Jun 03, 2015 | ||
| See all 65 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Farzad Nazem invest in?
Farzad Nazem invests primarily in Health Care, Software and Analytics startups, most often at Seed and Series A stage. Most of the 65 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Farzad Nazem's check size?
Farzad Nazem typically joins rounds of $750k–$6.5M at Seed, $2.8M–$14M at Series A and $6M–$50M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Farzad Nazem participates in.
How do I contact Farzad Nazem?
Public channels for Farzad Nazem include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Farzad Nazem last invest?
The most recent investment recorded for Farzad Nazem closed in Mar 2018. Shizune tracks 65 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
